The landscape of diabetes care is advancing with the arrival of GLP-1 patches . These novel patches offer a likely simpler alternative to shots for individuals dealing with type 2 diabetes . These patches deliver glucagon-like peptide-1 directly through the epidermis, bypassing the requirement for frequent injections and perhaps increasing complian